Growth Potential and Management's Will to Grow
Points 1 and 2 — is there room to grow, and does management actually intend to keep creating more room?
Fisher's fifteen points begin with the most basic qualifying question: does this company sell products or services with enough market potential for a sizable increase in sales for at least several years? A wonderfully-run company in a market that's already saturated or shrinking has a ceiling no amount of good management can fully overcome.
The second point is closely related but distinct: does management have the determination to keep developing new products or processes that will further increase sales potential once current growth avenues mature? A company can have one great growth product today and still stagnate later if management has no real appetite for what comes after it.
Together, these two points separate a company simply having a good current run from a company genuinely built to keep growing — the first asks about the size of today's opportunity, the second asks whether management will keep creating new ones.
| Point | What it actually asks | Why it's not redundant with the other |
|---|---|---|
| 1. Market potential | Is there enough room to grow sales substantially, for years, in what the company sells today? | A company can pass this today and still fail Point 2 if it has no plan beyond today's product |
| 2. Will to keep growing | Does management actively pursue new products or processes once current ones mature? | A company can pass this culturally even in a period when Point 1's current opportunity looks limited |
A company whose R&D spending and new-product pipeline have quietly shrunk even as its current flagship product still sells well is showing an early, easy-to-miss version of failing Point 2.
This particular failure mode is dangerous precisely because it's comfortable while it lasts. A company coasting on a successful current product often keeps posting solid results for years, management gets credit for capital discipline and efficiency, and nothing in the immediate numbers signals a problem — right up until the current product's growth naturally matures or a competitor catches up, at which point there's no next act ready to take over. Point 2 exists specifically to catch this pattern while it's still invisible in the reported numbers, which is also precisely when it's hardest to notice.
The current numbers can look fine for a surprisingly long stretch before the lack of a genuine "what's next" becomes visible in slowing growth — by the time it shows up in the reported figures, the underlying complacency has often been building for years.
For a short holding period, a company's current growth runway might be all that matters. For the multi-year holding periods Fisher's whole philosophy is built around, a company's demonstrated appetite for creating new growth avenues becomes just as important as what it's already selling today.
This is part of why Points 1 and 2 open the whole framework rather than appearing somewhere in the middle — everything that follows (the sales force, the margins, the management quality) only compounds into a great multi-year investment if there's actually enough runway, current and future, for those other strengths to keep being applied. A wonderfully-executed company with no growth runway left is a wonderfully-executed company that has, in Fisher's terms, already had its best years. That's also why Fisher treats these first two points as prerequisites rather than merely two items on a longer list — a company that clearly fails them isn't worth carrying through the remaining thirteen points at all, no matter how well it might score on execution, since none of that execution has anywhere left to compound into.
Not every stated growth ambition reflects a real Point 2 pass — management teams routinely talk about future growth regardless of whether they're actually building toward it. The distinguishing evidence is behavioral, not verbal: a rising, sustained R&D or new-product investment relative to the company's size, a track record of past product cycles that actually reached the market and succeeded commercially, and a demonstrated willingness to cannibalize an existing successful product with a better one rather than protecting it indefinitely. Words on an earnings call are cheap; a sustained pattern of investment and follow-through is the real evidence.
- Point 1 asks whether there's enough room to grow in what the company already sells; Point 2 asks whether management will keep creating new room once that runs out.
- A company can pass one of these two points without passing the other — they're testing genuinely different things.
- A shrinking new-product pipeline is an early, quiet warning sign that can precede slower growth by years.
- The longer your intended holding period, the more Point 2 matters relative to Point 1.
- Judge Point 2 by sustained investment and a track record of follow-through, not by how confidently management talks about future growth on a call.